Grifols SA risk profile

45 Elevated one input has moved against it

Measured 1 September 2026 from GRFS's filed statements. Recomputed nightly.

45 (Elevated), driven by Leverage and coverage at 59, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation42ElevatedStableOne-year price volatility — 32.2%
Operating pressure34NormalWorseningCosts outgrowing revenue — -0.8 percentage points
Cash conversion24NormalStableCapital spending against operating cash — 0.40x
Leverage and coverage59ElevatedEasingNet debt to EBITDA — 5.34x
Competitive position53ElevatedStableRevenue-growth gap against peers — -13.7 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Grifols SA